FIGS, Inc.
Description
FIGS, Inc. operates as a direct-to-consumer healthcare apparel and lifestyle company in the United States and internationally. It designs and sells healthcare apparel and scrubwear and non-scrubwear offerings, such as outerwear, underscrubs, footwear, compression socks, lab coats, loungewear, and other apparel. It also offers sports bras, performance leggings, tops, super-soft pima cotton tops, vests, fleeces, and jackets; necessities, scrub caps, lanyards, badge reels, tote bags, baseball caps, and beanies. The company markets and sells its products to healthcare professionals through its direct-to-consumer digital platform comprising website, mobile app, and B2B business, as well as retail store. FIGS, Inc. was founded in 2013 and is headquartered in Santa Monica, California. FIGS, Inc.
About
CEO
Ms. Catherine Eva Spear
Employees
343
Instrument type
Common Stock
Sector
Consumer Cyclical
Industry
Apparel Manufacturing
MIC code
XNYS
Address
2834 Colorado Avenue, Santa Monica, CA 90404, United States
×
![Enlarged Chart]()
Oscillators
Invalid data format
Summary
Invalid data format
Moving Averages
Invalid data format
Earnings
| Date | Estimate EPS | Actual EPS | Difference | % Surprise |
|---|---|---|---|---|
| Nov 8, 2024 | -0.01 | -0.01 | 0.00 | 0.00% |
| Aug 9, 2024 | — | 0.01 | — | — |
| May 10, 2024 | — | 0.01 | — | — |
| Feb 29, 2024 | 0.02 | 0.05 | 0.03 | 150.00% |
| Nov 3, 2023 | 0.02 | 0.03 | 0.01 | 50.00% |
Earnings estimate
|
Next Quarter
(Mar 2025)
|
Next Year
(Dec 2025)
|
|||
|---|---|---|---|---|
| Number of analysts | — | 6 | — | 10 |
| Average estimate | — | 0.01 | — | 0.08 |
| Low estimate | — | 0.00 | — | 0.05 |
| High estimate | — | 0.03 | — | 0.12 |
| Last year EPS | — | 0.01 | — | 0.02 |
[stock_revenue_estimate]
Growth estimates
Current qtr
-70.440%
Next qtr. (Mar 2025)
23.300%
Current year
-86.920%
Next year (Dec 2025)
374.120%
Next 5 years (per annum)
—
Past 5 years (per annum)
—
Income statement
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total reported revenue | 545.65M | 505.84M | 419.59M | 263.11M | 110.49M |
| Cost of revenue | 168.68M | 151.38M | 118.37M | 72.89M | 31.16M |
| Gross profit | 376.96M | 354.46M | 301.22M | 190.22M | 79.34M |
| Operating expense | |||||
| Research & development | — | — | — | — | — |
| Selling general and admin | 342.92M | 316.79M | 290.24M | 132.28M | 79.68M |
| Other operating expenses | — | — | — | — | — |
| Operating income | 34.05M | 37.67M | 10.98M | 57.94M | -347,000 |
| Non operating interest income | |||||
| Income | 6.78M | 1.71M | — | 136,000 | 460,000 |
| Expense | — | — | 239,000 | — | — |
| Other income expense | -13,000 | -647,000 | -885,000 | — | -1,000 |
| Pretax income | 40.81M | 38.73M | 9.86M | 58.08M | 112,000 |
| Tax provision | 18.17M | 17.54M | 19.42M | 8.32M | — |
| Net income | 22.64M | 21.19M | -9.56M | 49.76M | 112,000 |
| Basic EPS | 0.13 | 0.13 | -0.06 | 0.31 | 0.00 |
| Diluted EPS | 0.12 | 0.11 | -0.06 | 0.31 | 0.00 |
| Basic average shares | 168.07M | 165.27M | 159.18M | 160.15M | 160.15M |
| Diluted average shares | 168.07M | 165.27M | 159.18M | 160.15M | 160.15M |
| EBITDA | 36.99M | 39.59M | 11.52M | 58.89M | 170,000 |
| Net income from continuing op. | 22.64M | 21.19M | -9.56M | 49.76M | 112,000 |
| Minority interests | — | — | — | — | — |
| Preferred stock dividends | — | — | — | — | — |
Balance sheet
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Fiscal date | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
| Total assets | 473.21M | 395.06M | 311.75M | 133.86M | 62.60M |
| Current assets | |||||
| Cash | — | — | — | — | — |
| Cash equivalents | — | — | — | — | — |
| Cash and cash equivalents | 144.17M | 159.78M | 195.37M | 58.13M | 38.35M |
| Other short term investments | 102.52M | — | — | — | — |
| Accounts receivable | 6.55M | 6.29M | 1.65M | 1.70M | 1.38M |
| Other receivables | 920,000 | 578,000 | 788,000 | 4.08M | 377,000 |
| Inventory | 119.04M | 177.98M | 86.07M | 49.74M | 14.30M |
| Prepaid assets | 11.19M | 10.86M | 6.24M | 5.86M | 1.99M |
| Restricted cash | — | — | 2.06M | — | — |
| Assets held for sale | — | — | — | — | — |
| Hedging assets | — | — | — | — | — |
| Other current assets | 1.27M | 1.02M | 1.16M | 803,000 | — |
| Non current assets | |||||
| Properties | 43.06M | 15.31M | — | — | — |
| Land and improvements | — | — | — | — | — |
| Machinery furniture equipment | 15.34M | 12.67M | 6.96M | 4.64M | 2.16M |
| Construction in progress | 13.56M | 11,000 | 431,000 | 312,000 | 1.04M |
| Leases | 3.70M | 3.13M | 3.08M | 3.02M | 3.02M |
| Accumulated depreciation | -7.73M | -4.79M | -2.86M | -1.44M | -464,000 |
| Goodwill | — | — | — | — | — |
| Investment properties | — | — | — | — | — |
| Financial assets | — | — | — | — | — |
| Intangible assets | — | — | — | — | — |
| Investments and advances | — | — | — | — | — |
| Other non current assets | 19.63M | 12.23M | 10.80M | 7.01M | 446,000 |
| Total liabilities | 96.36M | 87.33M | 66.18M | 36.18M | 23.78M |
| Current liabilities | |||||
| Accounts payable | 14.75M | 20.91M | 14.60M | 11.97M | 10.52M |
| Accrued expenses | 7.91M | 26.16M | 24.68M | 6.68M | 3.19M |
| Short term debt | 8.23M | 3.41M | — | — | — |
| Deferred revenue | 10.40M | 10.67M | 6.19M | 4.80M | 1.98M |
| Tax payable | 5.71M | 3.37M | 7.70M | 3.18M | 2.55M |
| Pensions | 7.31M | 3.42M | 6.46M | 4.21M | 1.85M |
| Other current liabilities | — | 7.88M | 5.59M | 3.02M | 991,000 |
| Non current liabilities | |||||
| Long term debt | 38.88M | 15.76M | — | — | — |
| Provision for risks and charges | — | — | — | — | — |
| Deferred liabilities | — | — | — | — | — |
| Derivative product liabilities | — | — | — | — | — |
| Other non current liabilities | 183,000 | 176,000 | 243,000 | — | — |
| Shareholders equity | |||||
| Common stock | 16,000 | 16,000 | 16,000 | 15,000 | 15,000 |
| Retained earnings | 61.75M | 39.12M | 17.93M | 27.49M | -22.27M |
| Other shareholders equity | 5,000 | — | — | — | — |
| Total shareholders equity | 376.85M | 307.74M | 245.57M | 97.68M | 38.81M |
| Additional paid in capital | 315.08M | 268.61M | 227.63M | 70.18M | 61.07M |
| Treasury stock | — | — | — | — | — |
| Minority interest | — | — | — | — | — |
Cash flow statement
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
| Operating Activities | |||||
| Net Income | 22.64M | 21.19M | -9.56M | 49.76M | 112,000 |
| Depreciation | 2.94M | 1.92M | 1.42M | 946,000 | 517,000 |
| Deferred Taxes | -7.32M | -732,000 | -3.73M | -6.51M | — |
| Stock-Based Compensation | 45.80M | 37.46M | 81.14M | 8.71M | 179,000 |
| Other Non-Cash Items | 2.86M | 2.38M | — | — | — |
| Accounts Receivable | -603,000 | -4.43M | 3.34M | -4.02M | -1.27M |
| Accounts Payable | -6.19M | 6.32M | 2.86M | 1.21M | 2.72M |
| Other Assets & Liabilities | 55.47M | -89.06M | -33.61M | -30.94M | 2.09M |
| Operating Cash Flow | 115.59M | -24.96M | 41.86M | 19.15M | 4.34M |
| Investing Activities | |||||
| Capital Expenditures | -16.35M | -5.35M | -2.71M | -2.26M | -4.76M |
| Net Intangibles | — | — | — | — | — |
| Net Acquisitions | — | — | — | — | — |
| Purchase of Investments | -150.14M | -500,000 | — | — | — |
| Sale of Investments | 49.30M | — | — | — | — |
| Investing Cash Flow | -117.19M | -5.85M | -2.71M | -2.26M | -4.76M |
| Financing Activities | |||||
| Long-Term Debt Issuance | — | — | — | — | — |
| Long-Term Debt Payments | — | — | — | — | — |
| Other Financing Charges | -246,000 | 479,000 | -22.52M | -98,000 | 14.00M |
| Financing Cash Flow | -246,000 | 958,000 | 74.67M | -98,000 | 14.00M |
| Other Cash Details | |||||
| End Cash Position | 144.17M | 159.78M | 197.43M | 58.13M | 38.35M |
| Income Tax Paid | 21.10M | 11.90M | 15.00M | 18.16M | — |
| Interest Paid | — | — | — | — | — |
| Free Cash Flow | 84.57M | -40.68M | 63.73M | 19.49M | 1.77M |
Error: Invalid format in Holders JSON file.
Article
FIGS Announces Date of Fourth Quarter and Full Year 2024 Earnings Release, Conference Call and Webcast
SANTA MONICA, Calif.--(BUSINESS WIRE)--FIGS, Inc. (NYSE: FIGS), the global leading healthcare apparel brand dedicated to improving the lives of healthcare professionals, today announced it will release its fourth quarter and full year 2024 financial results on Thursday, February 27, 2025, after U.S. markets close. FIGS management will host a conference call that day at 2:00 p.m. PT / 5:00 p.m. ET to discuss its financial and business results and outlook. Prior to the call, FIGS will publish a f.
Feb 6, 2025
Article
Scrubs maker Figs rebuffs Story3 Capital's take-private offer
Figs said on Thursday it has rebuffed private equity firm Story3 Capital Partners' offer to acquire the scrubs maker.
Jan 16, 2025
Article
Figs stock price sits in a range: will it have a breakout in 2025?
Figs stock has lost momentum and remained in a consolidation phase in almost two years. It remained inside the support and resistance levels at $4.42 and $6.97 in this period, missing the strong stock surge in the United States.
Dec 31, 2024
